P2RY12 and acute coronary syndrome: The ACC/AHA 2021 guidelines for coronary artery revascularization and ESC 2023 guidelines for management of acute coronary syndrome recommends a loading dose of a P2Y12 inhibitor for patients undergoing PCI with stenting (COR I, LOE A) [19,37].